Emily H. Hall

759 total citations
18 papers, 519 citations indexed

About

Emily H. Hall is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Emily H. Hall has authored 18 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Oncology. Recurrent topics in Emily H. Hall's work include Microbial Inactivation Methods (4 papers), vaccines and immunoinformatics approaches (3 papers) and Immunotherapy and Immune Responses (3 papers). Emily H. Hall is often cited by papers focused on Microbial Inactivation Methods (4 papers), vaccines and immunoinformatics approaches (3 papers) and Immunotherapy and Immune Responses (3 papers). Emily H. Hall collaborates with scholars based in United States, Chile and India. Emily H. Hall's co-authors include Karl H. Schoenbach, Stephen J. Beebe, Sheila E. Crowe, David L. Brautigan, Peter B. Ernst, Ranajoy Chattopadhyay, Asima Bhattacharyya, David R. Jones, Marty W. Mayo and Aizhen Xiao and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Emily H. Hall

17 papers receiving 513 citations

Peers

Countries citing papers authored by Emily H. Hall

Since Specialization

Citations

This map shows the geographic impact of Emily H. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily H. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily H. Hall more than expected).

Fields of papers citing papers by Emily H. Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily H. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily H. Hall. The network helps show where Emily H. Hall may publish in the future.

Co-authorship network of co-authors of Emily H. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Emily H. Hall. A scholar is included among the top collaborators of Emily H. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily H. Hall. Emily H. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	A Prospective Study Assessing the Efficacy and Toxicity of Stereotactic Body Radiation Therapy for Oligometastatic Bone Metastases 2023 ·Advances in Radiation Oncology ·J Lee, Diana D. Shi, (unknown), Elizabeth Buckley, Lauren Gunasti, Emily H. Hall, (unknown), Beverly Spicer, Yu‐Hui Chen, (unknown), (unknown), Mai Anh Huynh, Alexander Spektor, Monica Krishnan, Tracy A. Balboni, Lauren Hertan	0
2	Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma 2021 ·Journal for ImmunoTherapy of Cancer ·Sapna P. Patel, Gina R. Petroni, Jason Roszik, Walter C. Olson, Nolan A. Wages, Kimberly A. Chianese‐Bullock, Mark E. Smolkin, Nikole Varhegyi, Elizabeth Gaughan, Kelly T. Smith, (unknown), Emily H. Hall, Sacha Gnjatic, Patrick Hwu, Craig L. Slingluff	33
3	Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63) 2021 ·Journal for ImmunoTherapy of Cancer ·Craig L. Slingluff, Gina R. Petroni, Kimberly A. Chianese‐Bullock, Nolan A. Wages, Walter C. Olson, Kelly T. Smith, (unknown), Lynn T. Dengel, Anna Dickinson, (unknown), Elizabeth Gaughan, William W. Grosh, Varinder Kaur, Nikole Varhegyi, Mark E. Smolkin, (unknown), Donna H. Deacon, Emily H. Hall	13
4	A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer 2017 ·Journal for ImmunoTherapy of Cancer ·Patrick M. Dillon, Gina R. Petroni, Mark E. Smolkin, David R. Brenin, Kimberly A. Chianese‐Bullock, Kelly T. Smith, Walter C. Olson, (unknown), (unknown), Christiana Brenin, Emily H. Hall, Craig L. Slingluff	50
5	Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia 2016 ·PLoS Pathogens ·Gerco den Hartog, Ranajoy Chattopadhyay, Amber Ablack, Emily H. Hall, Lindsay D. Butcher, Asima Bhattacharyya, Lars Eckmann, Paul R. Harris, Soumita Das, Peter B. Ernst, Sheila E. Crowe	52
6	Inhibition of Breast Cancer Metastasis Suppressor 1 Promotes a Mesenchymal Phenotype in Lung Epithelial Cells That Express Oncogenic K-RasV12 and Loss of p53 2014 ·PLoS ONE ·Emily H. Hall, Yuan Liu, Aizhen Xiao, Lisa S. Shock, David L. Brautigan, Marty W. Mayo, Prasad S. Adusumilli, David R. Jones	9
7	Loss of BRMS1 Promotes a Mesenchymal Phenotype through NF-κB-Dependent Regulation of Twist1 2014 ·Molecular and Cellular Biology ·Yuan Liu, Marty W. Mayo, Aizhen Xiao, Emily H. Hall, (unknown), Kyuichi Kadota, Prasad S. Adusumilli, David R. Jones	31
8	BRMS1 Suppresses Lung Cancer Metastases through an E3 Ligase Function on Histone Acetyltransferase p300 2012 ·Cancer Research ·Yuan Liu, Marty W. Mayo, Alykhan S. Nagji, Emily H. Hall, Lisa S. Shock, Aizhen Xiao, Edward B. Stelow, David R. Jones	36
9	Environmental and Lifestyle Influences on Disorders of the Large and Small Intestine: Implications for Treatment 2011 ·Digestive Diseases ·Emily H. Hall, Sheila E. Crowe	24
10	Inhibition of human breast cancer Matrigel invasion by Streptolysin O activation of the EGF receptor ErbB1 2011 ·Cellular Signalling ·Emily H. Hall, Volkan Gurel, Albert E. Dahĺberg, John McMichael, David L. Brautigan	9
11	Comprehensive Analysis of Phosphorylation Sites in Tensin1 Reveals Regulation by p38MAPK 2010 ·Molecular & Cellular Proteomics ·Emily H. Hall, Jeremy L. Balsbaugh, Kristie L. Rose, Jeffrey Shabanowitz, Donald F. Hunt, David L. Brautigan	30
12	Mechanism of hypoxia-inducible factor 1α-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium 2010 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Asima Bhattacharyya, Ranajoy Chattopadhyay, Emily H. Hall, (unknown), Peter B. Ernst, Sheila E. Crowe	40
13	Tensin1 Requires Protein Phosphatase-1α in Addition to RhoGAP DLC-1 to Control Cell Polarization, Migration, and Invasion 2009 ·Journal of Biological Chemistry ·Emily H. Hall, (unknown), Colin K. Choi, Alan F. Horwitz, David L. Brautigan	46
14	Nanosecond pulsed electric fields induce apoptosis in p53-wildtype and p53-null HCT116 colon carcinoma cells 2007 ·APOPTOSIS ·Emily H. Hall, Karl H. Schoenbach, Stephen J. Beebe	87
15	Nanosecond Pulsed Electric Fields Have Differential Effects on Cells in The S-Phase 2007 ·DNA and Cell Biology ·Emily H. Hall, Karl H. Schoenbach, Stephen J. Beebe	22
16	Nanosecond Pulsed Electric Fields (nsPEF) Induce Direct Electric Field Effects and Biological Effects on Human Colon Carcinoma Cells 2005 ·DNA and Cell Biology ·Emily H. Hall, Karl H. Schoenbach, Stephen J. Beebe	34
17	Dynamic effects and applications for nanosecond pulsed electric fields in cells and tissues 2005 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Stephen J. Beebe, P F Blackmore, Emily H. Hall, Jody A. White, Lauren K. Willis, (unknown), Juergen F. Kolb, Karl H. Schoenbach	1
18	An X-encoded alloantigenicity between BALB/c and C57BL/6 strains of mice 2003 ·Immunogenetics ·(unknown), (unknown), Emily H. Hall, (unknown), Thomas R. King	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact